论文部分内容阅读
目的:观察左氧氟沙星三联疗法与阿莫西林三联疗法治疗消化性溃疡的临床效果。方法:选取2014年7月-2016年6我院收治的126例消化性溃疡患者作为观察目标,按照不同治疗方法分为参照组和观察组,参照组63例应用阿莫西林三联疗法治疗,观察组63例应用左氧氟沙星三联疗法治疗,观察并比较两组临床疗效和不良反应情况。结果:观察组治疗总有效率显著优于参照组,对比显示组间存在统计学差异(P<0.05)。结论:左氧氟沙星三联疗法治疗消化性溃疡的临床效果优于阿莫西林三联疗法,并具有经济有效、安全可靠等优点,值得临床使用和全面普及。
Objective: To observe the clinical effect of levofloxacin triple therapy and amoxicillin triple therapy in the treatment of peptic ulcer. Methods: A total of 126 patients with peptic ulcer admitted in our hospital from July 2014 to June 2016 were selected as observation targets and divided into reference group and observation group according to different treatment methods. 63 cases of reference group were treated with amoxicillin triple therapy and observed Group 63 cases were treated with levofloxacin triple therapy, the clinical efficacy and adverse reactions were observed and compared between the two groups. Results: The total effective rate of the observation group was significantly better than that of the reference group. The comparison showed that there was a statistically significant difference (P <0.05). Conclusion: Levofloxacin triple therapy is superior to amoxicillin triple therapy in the treatment of peptic ulcer. It has the advantages of economy, safety and reliability. It is worth to be used clinically and widely.